Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 201

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Percutaneous Gastrostomy Device for the Treatment of Class II and Class III Obesity: Results of a Randomized Controlled Trial

Open access
Thompson, Christopher C, Abu Dayyeh, Barham K, Kushner, Robert, Sullivan, Shelby, Schorr, Alan B, Amaro, Anastassia, Apovian, Caroline M, Fullum, Terrence, Zarrinpar, Amir, Jensen, Michael D, Stein, Adam C, Edmundowicz, Steven, Kahaleh, Michel, Ryou, Marvin, Bohning, Matthew J, Ginsberg, Gregory, Huang, Christopher, Tran, Daniel D, Glaser, Joseph P, Martin, John A, Jaffe, David L, Farraye, Francis A, Ho, Samuel B, Kumar, Nitin, Harakal, Donna, Young, Meredith, Thomas, Catherine E, Shukla, Alpana P, Ryan, Michele B, Haas, Miki, Goldsmith, Heidi, McCrea, Jennifer, Aronne, Louis J · 2017 · American Journal of Gastroenterology

Abstract

Objectives: The AspireAssist System (AspireAssist) is an endoscopic weight loss device that is comprised of an endoscopically placed percutaneous gastrostomy tube and an external device to facilitate drainage of about 30% of the calories consumed in a meal, in conjunction with lifestyle (diet and exercise) counseling. Methods: In this 52-week clinical trial, 207 participants with a body-mass index (BMI) of 35.0–55.0 kg/m2 were randomly assigned in a 2:1 ratio to treatment with AspireAssist plus Lifestyle Counseling (n=137; mean BMI was 42.2±5.1 kg/m2) or Lifestyle Counseling alone (n=70; mean BMI was 40.9±3.9 kg/m2). The co-primary end points were mean percent excess weight loss and the proportion of participants who achieved at least a 25% excess weight loss. Results: At 52 weeks, participants in the AspireAssist group, on a modified intent-to-treat basis, had lost a mean (±s.d.) of 31.5±26.7% of their excess body weight (12.1±9.6% total body weight), whereas those in the Lifestyle Counseling group had lost a mean of 9.8±15.5% of their excess body weight (3.5±6.0% total body weight) (P<0.001). A total of 58.6% of participants in the AspireAssist group and 15.3% of participants in the Lifestyle Counseling group lost at least 25% of their excess body weight (P<0.001). The most frequently reported adverse events were abdominal pain and discomfort in the perioperative period and peristomal granulation tissue and peristomal irritation in the postoperative period. Serious adverse events were reported in 3.6% of participants in the AspireAssist group. Conclusions: The AspireAssist System was associated with greater weight loss than Lifestyle Counseling alone.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/ajg.2016.500

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 201

Metadata

Authors
Thompson, C. C., Abu Dayyeh, B. K., Kushner, R., Sullivan, S., Schorr, A. B., Amaro, A., Apovian, C. M., Fullum, T., Zarrinpar, A., Jensen, M. D., Stein, A. C., Edmundowicz, S., Kahaleh, M., Ryou, M., Bohning, M. J., Ginsberg, G., Huang, C., Tran, D. D., Glaser, J. P., Martin, J. A., Jaffe, D. L., Farraye, F. A., Ho, S. B., Kumar, N., Harakal, D., Young, M., Thomas, C. E., Shukla, A. P., Ryan, M. B., Haas, M., Goldsmith, H., McCrea, J., & Aronne, L. J.
Venue
American Journal of Gastroenterology
Published
2017-03
Volume
112
Issue
3
Pages
447-457
ISSN
0002-9270 (ISSN-L)
OpenAlex
W2560187051
Cited by
201
References
4
FWCI
21.91
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Percutaneous Gastrostomy Device for the Treatment of Class II and Class III Obesity: Results of a Randomized Controlled Trial. https://app.cochat.ai/papers/10.1038/ajg.2016.500
The paper
Thompson, C. C., Abu Dayyeh, B. K., Kushner, R., Sullivan, S., Schorr, A. B., Amaro, A., Apovian, C. M., Fullum, T., Zarrinpar, A., Jensen, M. D., Stein, A. C., Edmundowicz, S., Kahaleh, M., Ryou, M., Bohning, M. J., Ginsberg, G., Huang, C., Tran, D. D., Glaser, J. P., . . . Aronne, L. J. (2017). Percutaneous Gastrostomy Device for the Treatment of Class II and Class III Obesity: Results of a Randomized Controlled Trial. American Journal of Gastroenterology. https://doi.org/10.1038/ajg.2016.500

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.